Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-711-2 | CAS number: 591-27-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Justification for type of information:
- Data is from a study report.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: Combined 90 Day Feeding Study to assess teratogenicity
- Principles of method if other than guideline:
- The above test chemical was tested in a 90 days feeding study followed by teratology study.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 3-aminophenol
- EC Number:
- 209-711-2
- EC Name:
- 3-aminophenol
- Cas Number:
- 591-27-5
- Molecular formula:
- C6H7NO
- IUPAC Name:
- 3-aminophenol
- Details on test material:
- - Name of test material (as cited in study report): m-aminophenol
- Molecular formula (if other than submission substance): C6H7NO
- Molecular weight (if other than submission substance):109.13
- Substance type: Organic
- Physical state: solid
- Analytical purity: 99.93%
- Lot/Batch number: 49
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Taconic farms, Germantown, N.Y. 12526.
- Age at study initiation: No data available
- Weight at study initiation: No data available
- Fasting period before study: No data available
- Housing: All animals were housed individually in suspended wire mesh bottom cages except during mating.
- Diet (e.g. ad libitum): basal laboratory chow ad libitum.
- Water (e.g. ad libitum): Fresh tap water ad libitum
- Acclimation period: Twelve days
ENVIRONMENTAL CONDITIONS
- Temperature (°F):70 ± 1.13 deg F
- Humidity (%): 55.8 ± 4.6%
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: Feed
- Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: overnight
- Proof of pregnancy: Each female was checked in the morning for the presence of a sperm plug in the vagina or beneath the cages. Mating was verified by the microscopic examination of a vaginal washing for the presence of sperm cells
- After 1 days of unsuccessful pairing cohabitation continued for 3 more days.
- Further matings after 3 days of unsuccessful mating:: If mating had not occured after 3 days of cohabitation, females were separated from males and re-assigned to new males 2 days later. - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No Data Available
- Duration of treatment / exposure:
- 18 weeks
- Frequency of treatment:
- Daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 80, 200 and 700 mg/kg bw/day (average actual doses received)
- No. of animals per sex per dose:
- Twenty-five females per treatment group. A total of 100 females were used.
- Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- Parental animal: observation and examination
Each female was observed daily for condition (live, dead, moribund) and for signs of toxicity. Body weights were recorded on days 0, 6, 9, 12, 15 and 20 of gestation. - Oestrous cyclicity (parental animals):
- No Data Available
- Sperm parameters (parental animals):
- No Data Available
- Litter observations:
- The number of live fetuses and dead fetuses were recorded when pregnant females were sacrificed.
- Postmortem examinations (parental animals):
- Each females uterus and ovaries were exposed. Early and late resorptions were recorded as well as the total number of corpora lutea on both ovaries.
Following removal of all fetuses each females abdominal and thoracic cavity were examined for grossly abnormal tissues or organs. - Postmortem examinations (offspring):
- Each live fetuses were removed, gently dried, weighed and examined for external gross malformations and sex determination. Dead fetuses were preserved in 10% Neutral Buffered Formalin.
Approximately 1/3 of the live fetuses were preserved in Bouin's solution while the remaining 2/3 were eviscerated and stored in alcohol. These fetuses were later on stained with Alizarin Red-S. - Statistics:
- All statistical analysis compared the treatment groups with the control with a minimal level of significance set at p<0.05. Analysis of variance followed by a Student's t-test to isolate significant differences was used to compare body weights, fetal weights, corpora lutea, total implants and live fetuses. The number of resorptions (early and late), dead fetuses and post-implantations losses were compared by the Mann-Whitney U-test. The number of litters with malformations was compared with Fishers Exact test. Fetal sex ratios were compared by Chi-square (with Yates correction factor).
- Reproductive indices:
- No Data Available
- Offspring viability indices:
- No Data Available
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- not examined
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
Reduction in body weight were recorded in the two highest doses.
When changes in body weight were determined between days 0, 6, 9, 12, 15 and 20, the animals exposed to 700 mg/kg per day showed significantly less gain as compared to control. - Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- The females in the 700 mg/kg dosage group also consumed less food.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- effects observed, treatment-related
- Description (incidence and severity):
- REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
There was no significant effect on any parameter related to reproductive performance, except in the average number of corpora lutea which was marginally but statistically lower at 700 mg/kg (mean 12.2) as compared to controls (mean 14.2).
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 200 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- Dose descriptor:
- LOAEL
- Effect level:
- 700 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- mortality observed, non-treatment-related
- Description (incidence and severity):
- VIABILITY (OFFSPRING)
Only one fetus in the control group was found to be dead when pregnant females were sacrified on day 20 of gestation. - Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- GROSS PATHOLOGY (OFFSPRING)
There were no visceral malformations noted. A low incidence of full 14th ribs was noted at 200 and 700 mg/kg. However, the lack of other malformations and the presence of full 14th ribs in historical controls indicates that this is probably not a toxicologically significant effect. - Histopathological findings:
- not specified
- Other effects:
- no effects observed
- Description (incidence and severity):
- No significant effect on the number of live fetuses or fetal sex ratio between the treatment groups.
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not specified
Effect levels (F1)
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 700 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- viability
- body weight and weight gain
- gross pathology
- other: sex ratio
Overall reproductive toxicity
- Reproductive effects observed:
- yes
- Lowest effective dose / conc.:
- 700 mg/kg bw/day (actual dose received)
- Treatment related:
- yes
- Relation to other toxic effects:
- reproductive effects as a secondary non-specific consequence of other toxic effects
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The no observed adverse effect level (NOAEL) was condsidered to be 200 mg/kg/day when female rats were exposed to the test chemical during gestation.
- Executive summary:
In this reproductive and developmental toxicity study, male and female Sprague-Dawley rats were exposed to 3-aminophenol by diet for 90 days prior to mating (males and females) and from day 0-20 of gestation (females) at approx. 0, 80, 200, 700 mg/kg bw/day. There was a marked decrease in body weight throughout the treatment period in males (before mating) and in females (before mating and during gestation) at 700 mg/kg as compared to controls. This was accompanied by a significant decrease in food consumption in both male and females. At 200 mg/kg, the body weight was slightly lower in females before mating and during gestation, as compared to the controls. The mean number of corpora lutea per dam was significantly lower at 700 mg/kg (mean, 12.2) as compared to controls (mean 14.2). This effect was of doubtful significance as there were no adverse effects on any other parameter of reproduction at 700 mg/kg, as evident by no significant effect on the number of resorptions, the number of live fetuses, fetal sex ratio or fetal body weight. No visceral malformations were noted. A low incidence of supernumerary 14th ribs was noted at 200 mg/kg (1 fetus out of 239) and at 700 mg/kg (6 fetuses out of 262). This effect was of doubtful clinical significance due to lack of other malformations and due to supernumerary 14th ribs in historical control data. The no observed adverse effect level (NOAEL) was condsidered to be 200 mg/kg/day when female rats were exposed to the test chemical during gestation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.